Christian M. Gill, PharmD

Hartford Hospital

Disclosure(s): Cepheid: Grant/Research Support; Cumberland Pharmaceuticals: Grant/Research Support; Entasis: Grant/Research Support; Everest Medicines: Grant/Research Support; Shionogi: Grant/Research Support

Poster(s):

• (P-1261) In Vitro Persistence of Clinical Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates from Bone and Joint infections after Exposure to Daptomycin (DAP), Telavancin (TLV), and Vancomycin (VAN)
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET